Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of prescription-only medications used primarily for managing type 2 diabetes and, more recently, for weight management
Sodium-glucose co-transporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 169.00 per year only 14.08 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
By acting on these three receptors simultaneously, retatrutide offers a more potent approach to weight loss compared to current medications, as it works on multiple pathways to target obesity from various angles
The overall heterogeneity for HHF was I 2 = 0% (95% uncertainty intervals, 0 and 48.0%) (null) (Additional file 1: Table S3), with no evidence of publication bias (Egger test, P = 0.413)
Tschop M, Noguieras R, Ahren B
